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Background and Purpose:Moyamoya disease has been classically described by theAsian
experience, yet clinical aspects of moyamoya phenomena in the United States remain
vastly undeﬁned. The multifocal occlusive arterial disorder may be linked with numerous
conditions; however, later stages of this syndrome share common vascular pathophysiol-
ogy.This study is aimed at characterizing inpatient moyamoya cases in the United States
over a broad time span. Methods: A comprehensive analysis of the Nationwide Inpa-
tient Sample of the Healthcare Cost and Utilization Project (Releases 1–13, 1988–2004)
based on ICD-9-CM code 437 .5 was performed. Annual percentages and trends analyses
were conducted for demographic variables, admission characteristics, co-morbidities, and
procedures. Result: 2247 admissions of moyamoya cases were analyzed from a wide
geographic distribution throughout the United States between 1988 and 2004. Age at
admission varied considerably (mean 29.6±18.5years), affecting women more frequently
thanmen(61.9%).Variousracialgroupswereidentiﬁed(35.4%White,19.7%AfricanAmer-
ican, 5.6% Hispanic, 8.3% Asian or Paciﬁc Islander, 1.4% Native American). Admissions
were typically emergent (38.8%) or urgent (18.7%), although elective admissions occurred
(24.4%). Aside from moyamoya, sickle cell disease was diagnosed in 13.6%, ischemic
stroke in 20.7%, intracerebral hemorrhage in 7 .4%, transient ischemic attack in 3.4%, and
subarachnoid hemorrhage in 3.1%. Cerebral angiography was performed in 24.9% while
extracranial–intracranial bypass was done in 8.4% of patients. Conclusion: Moyamoya in
the United States is a heterogeneous condition affecting individuals of all ages across a
diverse racial spectrum and wide geographic distribution. Further recognition of moyamoya
syndrome may facilitate ongoing research and future therapeutic approaches.
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INTRODUCTION
Moyamoya is a chronic cerebrovascular disease ﬁrst described in
Japan in 1955 (Takeuchi and Shimizu,1957). It is characterized by
the narrowing or occlusion of proximal cerebral arteries, in par-
ticularly the distal internal carotid, proximal middle, or anterior
cerebral arteries, which often leads to hypertrophy of lenticulos-
triate arteries and bypassing of the occlusive segment. Moyamoya
vasculopathycanbecategorizedintothesyndromeandthedisease.
Moyamoya syndrome includes the vasculopathic abnormalities in
addition to associated conditions,while moyamoya disease has no
other associated risk factors. Moyamoya refers speciﬁcally to the
angiographic ﬁndings (Scott and Smith, 2009).
The diagnostic criteria are as follows: (1) stenosis or occlu-
sion of the anterior cerebral, middle cerebral or internal carotid
arteries, (2) an abnormality of the vasculature surrounding these
arteries,and (3) the presence of bilateral disease seen angiograph-
ically. Diagnosis of moyamoya syndrome has been deﬁned based
on cases that meet any two of these criteria. Conventional angiog-
raphy remains the gold-standard imaging technique for evalua-
tion of radiographic moyamoya; however, recent advances in MR
angiography are sufﬁcient in speciﬁc cases (Burke et al., 2009).
While this disease has been reported worldwide, the estimates
of incidence in the United States have been limited (Goto and
Yonekawa, 1992; Edwards-Brown and Quets, 1997; Graham and
Matoba, 1997; Numaguchi et al., 1997; Uchino et al., 2005). Fur-
thermore,there is data that suggests differences in presentation in
the North American population compared with the Asian pop-
ulation (Bruno et al., 1988; Numaguchi et al., 1997; Chiu et al.,
1998; Cloft et al.,1999;Yilmaz et al.,2001; Hallemeier et al.,2006;
Mesiwala et al., 2008).
In this study, we report the inpatient characterization of the
moyamoya phenomenon in the United States between 1988 and
2004. Speciﬁcally, demographic data, admission diagnoses, and
associated procedures are analyzed.
MATERIALS AND METHODS
The National Inpatient Sample (NIS) database from 1988 to
2004 (Releases 1–13, 1988–2004) was searched for records with
a diagnosis of moyamoya using the International Classiﬁcation
of Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-CM)
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code 437.5. Annual percentages and trends analyses were con-
ducted for demographic variables, admission characteristics, co-
morbiditiesandproceduresusingdescriptiveandfrequencyanaly-
sis in SPSS (version 13.0). Admission type and disposition upon
dischargewasanalyzedinadditiontotheassociateddiagnosesand
procedures during each admission. Using the diagnosis-related
group (DRG) codes 001 (craniotomy age >17 except for trauma)
or 003 (craniotomy age <17) and the ICD-9-CM procedure code
39.28 (extracranial–intracranial vascular bypass),the incidence of
surgical revascularization was calculated (Uchino et al., 2005).
Additionally, we reviewed the number of computerized tomog-
raphyof thehead(procedurecode87.03)andmagneticresonance
imaging of the brain (procedure code 88.91). Secondary diag-
noses were also obtained: sickle cell (diagnosis code 282) and
neuroﬁbromatosis (diagnosis code 23771 for speciﬁed and 23770
for unspeciﬁed). Race and ethnicity were determined based upon
the NIS database distinction: White, Hispanic, African American,
AsianAmerican(includingPaciﬁcIslander),andNativeAmerican.
RESULTS
We analyzed 2247 inpatient admissions with moyamoya between
1988 and 2004. In this cohort, the mean age of the patients was
29.6±18.5, ranging from 0 to 101years in age. Women were
admitted for moyamoya more often than men (61.9%, Figure 1).
BaseduponthecategoriesdeterminedbytheNISdatabase,thedis-
tributionof moyamoyadiseaseamongethnicitiesduringthistime
periodisasfollows:Whites35.4%,AfricanAmerican19.7%,Asian
or Paciﬁc Islanders 8.3%, Hispanics 5.6%, and Native Americans
1.4%.Whencomparinggenderandethnicity,allethnicitiesexcept
African Americans displayed a female predominance (Figure 2).
The majority of admissions were for emergent care (38.8%),
followedbytheelectiveadmissiontype(24.4%)andurgentadmis-
sions (18.7%). Inpatient stays were on average 7.75days. In addi-
tiontomoyamoya,thepatientsalsopresentedwithotherdiagnoses
uponadmission.Allofthepatientswerecodedashavingsomesort
of cerebrovascular disease, while 20.7% of patients were admit-
ted with the diagnosis of an ischemic stroke (Goldstein, 1998).
Intracerebralhemorrhageoccurredin7.4%ofcases,subarachnoid
hemorrhage in 3.1% or another unspeciﬁc intracranial hemor-
rhagein0.6%of admissions.Thediagnosisof atransientischemic
attack (TIA) was present in 3.4% of admissions,while anemia was
coded in 13.5% of this cohort. Of note, sickle cell disease or trait
wasnotedin13.6%ofallmoyamoyacases,whileonly51caseswere
concomitantly diagnosed with neuroﬁbromatosis. The principal
diagnosis in patients admitted for moyamoya follows a similar
orderandincludedischemicstroke(9.2%),anemia(7.6%),intrac-
erebral hemorrhage (5.5%), subarachnoid hemorrhage (2.4%),
and TIA (1.8%).
Cerebral angiography was the most common procedure per-
formed in these patients (24.9%). Surgical revascularization was
performed in 23.7% of patients. Speciﬁcally, craniotomies were
done on patients greater than 17years of age in 10.1% of patients,
while patients between the ages of 0 and 17 received craniotomies
in5.2%of thecases.Cerebralarterybypasseswerealsoperformed
inthesepatients(9.7%)withtheextracranial–intracranialvascular
bypass being the most common (8.4%). Packed red cell transfu-
sions were indicated in 11.0% of this population. The principal
procedures followed a similar distribution: cerebral angiography
(13.1%),cerebrovascularbypass(7.9%),andpackedredcelltrans-
fusion (4.3%, Figure 3). Over the 17-year period, computerized
tomographyof theheadwasonlyreportedin183cases,whileMRI
was reported in 178 cases.
Todeterminetheoutcomesof patientsafteradmission,weana-
lyzed the inpatient deaths and discharge dispositions. There was
a 3.0% mortality rate during hospitalization, while the majority
of patients were routinely discharged (76.8%). Patients were also
discharged to short-term hospital facilities (4.6%), home health
care (4.3%), or other type of facility (9.4%).
DISCUSSION
MoyamoyaintheUSaffectsabroadspectrumof individualsfrom
diverse backgrounds and age groups. According to the NIS data-
base,thenumberofinpatientmoyamoyacaseshasbeenincreasing;
however,thisnumberisdeceptivebecausethenumberof hospitals
sampledhasalsoincreased.Moyamoyaisalifelongprocessandhas
been seen in patients ranging from newborn individuals to those
in their ninth decade. Since these patients are relatively stable,
this chronic disorder is often seen with other co-morbidities, and
patients are often subject to developing other pathologies.
Ingeneral,thereweremoremoyamoyaadmissionsinthefemale
cohort (3:2 female-to-male), consistent with previous data sug-
gesting a 2:1 ratio (Scott et al., 2004; Baba et al., 2008). While
females generally had more admissions, there was a greater dif-
ference between female and male admissions between the ages of
19 and 55years of age. Over the 17-year period based upon age
quartiles(0–18,19–35,36–55,greaterthan55yearsof age),female
admissions for moyamoya were greater in the 19–35 age group
(3:1 female-to-male), and 36–55 age group (2:1) compared with
the more extreme age groups (1:1). There was variability among
the years. For instance,males less than 18years of age were admit-
ted for moyamoya more often than females less than 18years of
age prior to 1998 at which point females in this age group were
more prevalent. Furthermore, there was a signiﬁcant increase in
females between the ages of 36 and 55years of age after 1994.
BasedupontheNISclassiﬁcation,theWhiteethnicityconsisted
of the majority of moyamoya admissions. However, for patients
under 19years of age, the African American ethnicity was the
majority(Whites9.9%,AfricanAmericans11.7%,AsianorPaciﬁc
Islanders2.4%,Hispanics2.4%,andNativeAmericans0.3%of the
total admission population). This ﬁnding may be due to an asso-
ciation between moyamoya and sickle cell disease (Pegelow,2001;
Riebel et al., 2003; Gebreyohanns and Adams, 2004), as sickle cell
disease is more prevalent in the African American population.
Not all of the African American population has been concomi-
tantly diagnosed with sickle cell disease,as only 1.3% of the entire
population was diagnosed with a red cell blood disorder between
the ages of 0 and 17years.
While this study does not have the ability to comment on med-
ical treatment, the percentage of bypasses coded increased over
time and peaking in the year 2001. In 1988, of the cases coded
none of the patients underwent a bypass, while in 2001, 21.5% of
patients with moyamoya underwent bypass. After 2001,there was
a decline in the percentage of patients who underwent bypass as
evidenced by only 10.3% of patients undergoing bypass in 2004.
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FIGURE1|O v e r all, there was a higher percentage of female relative to male hospital admissions for moyamoya; however, in general, there were
fewer males and females over 55years of age who presented as hospital admissions. Of note after 1994, there was a decline in male hospital admissions
in patients less than 19years of age.
FIGURE2|I nt h eUnited States, there is a predominance of female-to-male admissions for moyamoya. Over this time period, there is a similar number
of White and African American males, while more White than African American females were admitted to the hospital with moyamoya during that time.
The incidence of cerebral angiography varied over time, ranging
from 13.9 to 47.1%; however, there was no particular trend in the
incidence of this procedure.
Moyamoya in the US may be distinct from Asian descriptions.
It is important to note that deﬁning moyamoya is important
when analyzing the NIS database. The NIS does not distinguish
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FIGURE 3 |Angiography remains the most common procedure associated with patients admitted for moyamoya, while there has been progressively
more cerebral artery bypasses from 1992–2004.
between moyamoya disease and moyamoya syndrome. It is likely
that the majority of the cases are likely moyamoya syndrome due
to the presence of various pathologies; however, this information
is unable to be ascertained based upon this data alone. Although
moyamoya may be rare, it is important to study these cases not
onlyforthecareofthesepatients,butalsobecausemoyamoyasyn-
dromemayprovideinsightonthechronicdevelopmentandroleof
collaterals over time. Although surgical and nascent endovascular
techniques,such as stenting,may be utilized to revascularize these
individuals,the role and impact of these interventions needs to be
compared with natural history in the US. While it has not been
shownthatindiscriminatemoyamoyascreeningisbeneﬁcial,there
has been a correlation with early screening for unilateral moy-
amoya onset and decreased stroke burden and improved clinical
outcome (Scott and Smith, 2009).
The moyamoya phenomenon is a varied disease, and this cod-
ing system does not differentiate between moyamoya disease and
moyamoya syndrome; however, it is more likely to actually be a
variant of the moyamoya phenomenon because it is such a rare
and speciﬁc condition. It is difﬁcult to be certain that the same
patients are not being counted more than once due to a second
need for admission.As noted by Uchino et al. (2005)there may be
a selection and ascertainment bias as patients of Asian origin may
be given the diagnosis of moyamoya more commonly.
Due to the fact that this is a national database, this study is
restricted to the information inputted by the various hospitals
throughout the nation. It is only a study of inpatient hospitaliza-
tions and does not include outpatient data. Unfortunately,it does
notelucidatehowthesepatientswerediagnosed.Typically,thisdis-
easeprocessisdiagnosedthroughangiography,andonly24.9%of
the patients reported here had this procedure. Thus,patient likely
were admitted with a prior diagnosis of moyamoya.An additional
possibilityisthataparticularpatientmayhavebeenadmittedmul-
tipletimes,suggestingaselectionbias.Still,thenumberspresented
herelikelyareunderestimatingthetotalnumberof patientsacross
the United States. The data gathered is approximates 20% of the
stratiﬁed sample of community hospitals across the United States.
During each year period, there are a different number of states
participating in the database, ranging from 8 states in 1988 to 37
statesin2004.Thus,eveninthelatestversionnotallstatesarerep-
resented.Furthermore,thesensitivityandspeciﬁcityof thecoding
systemisunknown.However,thisisthemostcomprehensivedata-
base in the United States and is speciﬁc for moyamoya, providing
an objective measure. Moyamoya is a relatively rare phenomenon;
thus,itisunlikelythatonewouldpositivelycodemoyamoya,lead-
ingtorelativelyhighspeciﬁcity.Thisdoessuggestthatthenumber
of cases reported in this study is an underestimate of the cases in
the United States.
CONCLUSION
Moyamoya in the United States remains a heterogeneous disease
processthataffectsadiversepopulationof individualsoverawide
geographic distribution. Continued cataloging of speciﬁc aspects
of moyamoya disease and syndrome may improve the character-
ization of this disease process and foster improved research and
therapeutic approaches.
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